Overview
Peter C. Pan, MD is a board-certified assistant professor of neurology in the Division of Neuro-Oncology. He specializes in the treatment of brain tumors. He studied molecular biology and neurobiology at the University of California Berkeley, medicine at the State University of New York Downstate, and clinical neurology residency at the University of California Davis. He completed subspecialty training in Neuro-Oncology at NewYork-Presbyterian / Columbia University Irving Medical Center and NewYork-Presbyterian Weill Cornell Medical Center.
Areas of Expertise / Conditions Treated
- Anaplastic Astrocytoma
- Astrocytoma
- Brain Metastases
- Brain Stem Glioma
- Brain Tumor
- Central Nervous System Tumors
- Choroid Plexus Carcinoma
- Choroid Plexus Papilloma
- Ependymoma
- Glioblastoma
- Hemangioblastoma
- Leptomeningeal metastases
- Medulloblastoma
- Meningioma
- Neurofibromatosis
- Oligodendroglioma
- Second Opinion
- Spinal Cord Tumor
Academic Appointments
- Assistant Professor of Neurology at the CUMC
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
- NewYork-Presbyterian / Weill Cornell Medical Center
Gender
- Male
Schedule an Appointment
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
- Aetna Signature Administrators
- EPO
- HMO
- Medicare Managed Care
- NYP Employee Plan
- NY Signature
- POS
- PPO
- Student Health
Affinity Health Plan
- Essential Plan
- Medicaid Managed Care
AgeWell
- Medicare Managed Care
- Special Needs
Amida Care
- Special Needs
Cigna
- EPO
- Great West (National)
- HMO
- Medicare Managed Care
- POS
- PPO
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicaid Managed Care
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross/Blue Shield
- EPO
- HMO
- Medicare Managed Care
- PPO
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
Fidelis Care
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Medicare Managed Care
Local 1199
- Local 1199
MagnaCare (National)
- MagnaCare
Medicare
- Railroad
- Traditional Medicare
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
Quality Health Management
- Quality Health Management
RiverSpring
- Special Needs
UnitedHealthcare
- Compass (Exchange)
- Empire Plan
- HMO
- Medicaid (Community Plan)
- Medicare Managed Care
- Oxford Freedom
- Oxford HMO
- Oxford Liberty
- POS
- PPO
VNSNY CHOICE
- Medicare Managed Care
- SelectHealth
- Special Needs
WellCare
- Medicaid Managed Care
- Medicare Managed Care
World Trade Center Health Plan
- World Trade Center Health Plan
Credentials & Experience
Education & Training
- State University of New York Health Science Center at Brooklyn
- Internship: University of California Davis Medical Center
- Residency: University of Calfornia Davis Medical Center
Honors & Awards
His work has been presented at national specialty meetings across the country, and he has authored a textbook chapter and review article on clinical management in neuro-oncology.
Research
Dr. Peter Pan's research interests include clinical treatments in neuro-oncology and mechanisms of treatment resistance. He is involved in ongoing research reviewing patterns of distant recurrence in adult gliomas, diagnostic imaging features of primary central nervous system lymphomas, and effects of upfront radiation on outcomes in atypical meningiomas. He is also involved in ongoing collaboration with colleagues at Cornell reviewing quality metrics for clinical trials, and with colleagues from biophysics and computational chemistry at UC Davis researching hot spots in protein-protein binding free energy of the programmed death ligand 1 (PD1-PDL1) immune checkpoint, a frequently-targeted axis in oncology.